Vimarsana
Biggest News Aggregation in the World

Single Dose Portion News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Single Dose Portion. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Single Dose Portion Today - Breaking & Trending Today

Protagenic Therapeutics, Inc.: Protagenic Therapeutics' Stress-Regulating Peptide Demonstrates Exceptional Safety in Single Dose Portion of Phase I Trial, Paving the Way for Next Steps Toward Potential Breakthrough Treatments in Stress Related Neuropsychi - Vimarsana News

Protagenic Therapeutics, Inc.: Protagenic Therapeutics' Stress-Regulating Peptide Demonstrates Exceptional Safety in Single Dose Portion of Phase I Trial, Paving the Way for Next Steps Toward Potential Breakthrough Treatments in Stress Related Neuropsychi

Published: May 22, 2024

No Clinically-Relevant Adverse Events Reported in Single Dose Portion, Multiple Dose Portion to CommenceInvestor Call Scheduled for today, Wednesday, May 22, at 10:00 am ET to Discuss Potential Impact

Source: finanznachrichten.de
Related Topics:
New YorkUnited StatesRobertb SteinCompany ContactAdvisory IncProtagenic Therapeutics IncSingle Dose PortionMultiple Dose PortionCall ScheduledDiscuss Potential ImpactProtagenic TherapeuticsChief MedicalAccess CodeLooking StatementsChief Financial OfficerRelations ContactIhr Portfolio
Protagenic Therapeutics' Stress-Regulating Peptide Demonstrates Exceptional Safety in Single Dose Portion of Phase I Trial, Paving the Way for Next Steps Toward Potential Breakthrough Treatments in Stress Related Neuropsychiatric Disorders - Vimarsana News

Protagenic Therapeutics' Stress-Regulating Peptide Demonstrates Exceptional Safety in Single Dose Portion of Phase I Trial, Paving the Way for Next Steps Toward Potential Breakthrough Treatments in Stress Related Neuropsychiatric Disorders

Published: May 22, 2024

No Clinically-Relevant Adverse Events Reported in Single Dose Portion, Multiple Dose Portion to Commence Investor Call Scheduled for today, Wednesday, May 22, at 10:00 am ET to Discuss Potential Impact on PTSD, Depression, Anxiety, Addiction, and Obesity NEW YORK, NY / ACCESSWIRE / May 22, 2024 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX), a leader in biopharmaceutical innovation, today announced the complete safety data set from

Source: wn.com
Related Topics:
Single Dose PortionMultiple Dose PortionInvestor Call ScheduledDiscuss Potential Impact